Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 20 | $3,124,167 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 18 Jul 2023 | Sale | 30,000 | 13.74 | 412,200 | D |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jul 2023 | Sale | 30,000 | 11.72 | 351,600 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 26 Jul 2023 | Sale | 20,000 | 14.41 | 288,200 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 25 Jul 2023 | Sale | 20,000 | 14.3 | 286,000 | D |
05 Jun 2023 18:29 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 01 Jun 2023 | Sale | 25,000 | 8.58 | 214,500 | D |
18 Jan 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Jan 2024 | Sale | 18,000 | 10.93 | 196,740 | D |
19 Dec 2023 19:22 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Dec 2023 | Sale | 18,000 | 9.6 | 172,800 | D |
17 Aug 2023 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Aug 2023 | Sale | 18,000 | 9.25 | 166,500 | D |
05 Jun 2023 18:29 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 02 Jun 2023 | Sale | 17,865 | 8.93 | 159,534 | D |
19 Sep 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Sep 2023 | Sale | 18,000 | 8.66 | 155,880 | D |
17 Nov 2023 17:52 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2023 | Sale | 18,000 | 6.51 | 117,180 | D |
18 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Oct 2023 | Sale | 18,000 | 6.3 | 113,400 | D |
19 Jan 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jan 2023 | Sale | 10,000 | 9.1561 | 91,561 | D |
19 Dec 2022 17:32 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Dec 2022 | Sale | 10,000 | 8.8525 | 88,525 | D |
17 Nov 2022 18:47 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2022 | Sale | 5,059 | 12.7 | 64,249 | D |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Feb 2023 | Sale | 7,486 | 8.33 | 62,358 | D |
17 Nov 2022 18:47 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2022 | Sale | 4,941 | 11.9153 | 58,873 | D |
18 Oct 2022 17:08 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 14 Oct 2022 | Sale | 5,000 | 11.21 | 56,050 | D |
18 Oct 2022 17:08 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 14 Oct 2022 | Sale | 5,000 | 10.6259 | 53,130 | D |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Feb 2023 | Sale | 1,768 | 8.42 | 14,887 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)